Zimmer Biomet shareholders approve amended stock plan and officer liability limit
At its May 29, 2025 annual meeting, Zimmer Biomet shareholders approved an amended 2009 Stock Incentive Plan that adds 10,000,000 shares and extends the plan to May 31, 2035. They also approved a charter amendment that limits personal monetary liability for certain officers for breach of the duty of care. The changes expand the share pool available for equity awards and alter officer liability protections for shareholders.
Key points
- The amended stock incentive plan adds 10,000,000 shares and extends its term three years to May 31, 2035; the plan passed with 154,414,891 votes for and 13,644,592 against.
- The charter amendment limiting certain officers' personal liability passed with 149,159,508 votes for and 18,926,602 against.
- Shareholders elected ten directors for one-year terms ending at the 2026 annual meeting.
- PricewaterhouseCoopers LLP was ratified as independent registered public accounting firm for 2025, with 173,729,736 votes for and 7,965,373 against.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:42 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 03, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.